Regeneron 1526: A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Dupilumab Monotherapy in Patients ?12 to <18 Years of Age, with Moderate-to-Severe Atopic dermatitis

Project: Research project

Project Details

StatusFinished
Effective start/end date7/1/179/27/20

Funding

  • Northwestern University
  • Regeneron Pharmaceuticals, Inc.